Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Consumer home-testing healthcare company MyHealthChecked upgraded its annual earnings guidance amid continued strong demand for Covid-19 tests.
Adjusted earnings before interest, tax, depreciation and amortisation for the year through December were expected to amount to at least £2.5 million, swinging from a year-on-year loss of £2.7 million.
Revenue was seen jumping to around £16.3 million, up from £49,500 year-on-year.
'MyHealthChecked can confirm that it continued to experience strong trading throughout the fourth quarter due to the increased demand for reinstated day-2 PCR test kits as well as the launch of its rapid antigen test and verification service for inbound and outbound travellers,' the company said.